2021 Revenues ($USD) : $8,465,982,000
2021 Revenues (foreign currencies) : € 7,426,300,000
2021 R&D spend : $421,572,000
2021 Number of Employees : 64,317
Fiscal Year End : 12/31/2020
Key People : Anna Maria Braun, CEO; Jean-Claude Dubacher, CEO at B. Braun of America; Annette Beller, board member, finance, taxes and controlling, central service departments; Meinrad Lugan, board member, hospital care division; Stefan Ruppert, board member, chief human resources officer and director, labor relations; Joachim Schulz, board member, B. Braun Aesculap division; Markus Strotmann, board member, B. Braun Avitum division.

About the company: B. Braun began as a pharmacy selling medical herbs through the mail in Melsungen, Germany, in 1839. Still based in Melsungen, the company now offers more than 5,000 different healthcare products thanks to its more than 60,000 employees across more than 60 countries throughout Asia, Europe, North America, the Pacific Rim and South America. Among its offerings are products for infusion therapy and pain management as the company seeks to tackle challenges including opioid abuse issues, hospital-acquired malnutrition and hazardous drug exposure while eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. The company is a full line supplier of IV therapy products, including IV solutions, and drug delivery systems. Other offerings include products in the area of anesthesia, renal therapies, wound management and vascular access. Aesculap, B. Braun’s American unit, was initially founded in Germany in 1867 before Aesculap Inc. — the American division — was founded in 1977 in Center Valley, Pennsylvania. Aesculap AG was incorporated into the B. Braun Group in 1998 and manufactures surgical equipment, including sutures, handheld surgical instruments, implants, and electrosurgical devices and powers systems. B. Braun’s current U.S. operations are headquartered in Bethlehem, Pennsylvania, with primary U.S. manufacturing facilities located in Allentown, Pennsylvania, Irvine, California, Carrollton, Texas, and the Dominican Republic. The company’s U.S. operations are currently headed up by CEO Jean-Claude Dubacher, who took over for longtime company leader Carroll Neubauer at the start of 2020 after he had held the role of CEO of B. Braun Medical since 1997.  –SW